MedPath

Comparing between prescription and not prescription of vitamin D on recurrence of endometriosis related pains

Phase 2
Conditions
Endometriosis of pelvic peritoneum.
Endometriosis of pelvic peritoneum
Registration Number
IRCT2013021912151N3
Lead Sponsor
Minimally Invasive Surgery Research Center of Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
22
Inclusion Criteria

Inclusion criteria : 15-45 years women that during laparoscopy endometriosis is confirmed and in second menstruation after operation the score of pain for dysmenorrhea or pelvic pain will be 3 or more.
Exclusion criteria : The women that have received vitamin D in last 6 months, the women that will not continue the follow up.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of dysmenorrhea. Timepoint: 2 cycles after operation. Method of measurement: VAS test.;Severity of dysmenorrhea. Timepoint: before operation. Method of measurement: VAS test.;Severity of dysmenorrhea. Timepoint: 4 months after starting vitamin D. Method of measurement: VAS test.
Secondary Outcome Measures
NameTimeMethod
Dysmenorrhea. Timepoint: 4 months after starting vitamin D. Method of measurement: VAS test.
© Copyright 2025. All Rights Reserved by MedPath